Atara Biotherapeutics, Inc. (ATRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 226.92M |
| Enterprise Value | 271.24M |
| P/E Ratio | -7.93 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 20.27 |
| Price/Book Ratio | -3.24 |
| Enterprise/Revenue | 21.66 |
| Enterprise/EBITDA | -6.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -3.69 |
| Operating Margin | -3.44 |
| Return On Assets | -0.79 |
| Return On Equity | 0.39 |
| Revenue | 120.77M |
| Revenue/Share | 0.26 |
| Gross Profit | 99.56M |
| EBITDA | 38.63M |
| Net Income | 32.69M |
| Diluted EPS | 2.57 |
| Total Cash | 9.92M |
| Total Cash/Share | 0.65 |
| Total Debt | 9.57M |
| Total Debt/Equity | -0.25 |
| Current Ratio | 1.72 |
| Book Value Per Share | -2.47 |
| 52-Week Change | -35.8 |
| 52-Week High | 19.15 |
| 52-Week Low | 3.92 |
| Moving Average 50 Days | 9.01 |
| Moving Average 200 Days | 7.81 |
| Average Volume | 38,746 |
| Shares Outstanding | 10.04M |
| % Held by Institutions | 29.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 20, 2024 |